NADEGE AKIL: Open Payments
NPI 1982299327 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$191 in 9 payments from 6 companies in 2025. Trend: 2023 $156 · 2024 $224 · 2025 $191
Food & beverage: $191
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 2 | $48 |
| GENZYME CORPORATION | 2 | $39 |
| Janssen Biotech, Inc. | 2 | $35 |
| Therakos LLC | 1 | $33 |
| Incyte Corporation | 1 | $21 |
| Genentech USA, Inc. | 1 | $15 |
Products named: REZUROCK, SARCLISA, NIKTIMVO, TALVEY, TECVAYLI, Polivy.
Industry payments across PA — which companies pay providers there.
